Arixtra
NDC 67457-593, fondaparinux sodium, injection, solution, from Mylan Institutional LLC.
- Product NDC
- 67457-593
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021345
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-593 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FONDAPARINUX SODIUM5 mg/.4mL
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-593-04 | 67457059304 | 10 SYRINGE, GLASS in 1 CARTON (67457-593-04) / .4 mL in 1 SYRINGE, GLASS (67457-593-00) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d3b30c68-cf45-4b46-8ba6-72090f7ba01aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-593
Use it
Look up 67457-593 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-593 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-593. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.